News
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Beacon Therapeutics spun out by Syncona and Oxford raises £96 million for retinal gene therapy
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Oxford Alumna and Cancer Survivor Launches New App to Support Cancer Patients
- MBA Graduate Ani Hakyuni’s own experience surviving cancer inspires new startup.
- The app, Vann, will create support groups for people battling cancer.
- Vann will provide key insights to support clinician decision making in oncology.
OUI Incubator welcomes cohort six to Phase 2
Take a glimpse into the future with startups emerging from OUI’s incubator.
Oxford University retains No. 1 spot for spinouts
The 2023 Spotlight on Spinouts report once again underlines Oxford’s leading position in spinout creation. The report underlines Oxford Science Enterprises’ positive impact on Oxford’s spinout community, while investments into Oxford spinouts remain high, despite UK-wide downturn.
Top universities boost investor confidence with new spinout framework to spur economic growth
The University of Oxford partners with top universities and investors to agree terms which will greatly increase the UK’s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
10 Oxford companies changing the world
Discover 10 Oxford University companies with their sights firmly set on defining the future.
FluoRok: the future of fluorination
FluoRok is revolutionising the production of fluorochemicals with their HF-free fluorination processes that are safer, more efficient, and environmentally conscious. Led by Moissan-prize winner Professor Véronique Gouverneur FRS and CEO Dr Gabriele Pupo, the team is building on over two decades of research to provide a solution to the challenges of the current production process.
Oxford University Creates 300 Companies: A Milestone in Research Commercialisation
With companies created ranging from AI and quantum computing to vaccine developers and social ventures tackling poverty, Oxford University hits milestone in company creation, cementing its status as a leading institution in research commercialisation globally.
CEO Spotlight: James Palles-Dimmock from Quantum Motion
Quantum Motion, an Oxford firm making quantum computers on silicon a reality, is riding high after a £42m funding round. To find out more, OUI's Gregg Bayes-Brown spoke with QM’s CEO James Palles-Dimmock.